ACB $2.630 (1.15%)

ACNNF $0.134 (11.6%)

AERO $1.030 (6.19%)

AGEEF $0.224 (-6.5%)

ALEAF $0.500 (5%)

AMMJ $0.132 (-11.92%)

APHA $5.500 (4.36%)

ARNA $47.020 (-0.63%)

ATT:CNX $0.080 (0%)

ATTBF $0.004 (-5.13%)

AUSA:CNX $0.450 (0%)

AUSAF $0.340 (0%)

AVXL $2.440 (0%)

BAMM:CNX $0.680 (0%)

BBM:CNX $0.100 (0%)

BBRRF $0.077 (1.45%)

BE:CNX $0.020 (-20%)

BIO:CNX $0.190 (5.56%)

BLEVF $0.013 (-37.29%)

BLO:CNX $0.425 (2.41%)

BLOZF $0.329 (6.1%)

BUDZ $0.345 (-1.43%)

BXNG $0.395 (6.76%)

CADMF $0.066 (10.67%)

CALI:CNX $0.075 (-6.25%)

CANN $0.630 (-0.87%)

CARA $16.570 (1.04%)

CBII:CNX $0.100 (5.26%)

CBIIF $0.083 (3.91%)

CBWTF $0.473 (2.14%)

CGC $20.680 (-2.13%)

CGRW $0.150 (7.14%)

CHOO:CNX $0.180 (0%)

CHOOF $0.140 (7.69%)

CNAB $0.160 (-4.76%)

CNBX $0.105 (0%)

CNGGF $0.265 (-1.68%)

CODI $24.980 (0.52%)

CPMD $1.840 (0%)

CRBP $5.040 (-0.79%)

CRON $7.280 (-0.27%)

CROP:CNX $0.010 (0%)

CRTPF $3.000 (0.67%)

CRXPF $0.011 (7%)

CSI:CNX $0.085 (13.33%)

CTST $0.844 (0.75%)

CURR $2.780 (15.83%)

CVSI $1.190 (-8.11%)

DIGP $0.088 (-1.69%)

DXBRF $0.203 (-4.48%)

EAPH $0.001 (0%)

EAT:CNX $0.045 (0%)

EEVVF $0.113 (10.59%)

EMHTF $0.285 (32.56%)

EPWCF $0.022 (-21.6%)

EVIO $0.060 (-7.03%)

FFRMF $0.025 (-27.64%)

FFT:CNX $0.040 (0%)

FNNZF $0.054 (-16.46%)

FSDDF $4.530 (9.47%)

GGTTF $0.160 (0%)

GLDFF $0.018 (15.77%)

GLH:CNX $0.025 (25%)

GLNNF $0.031 (-4.56%)

GNBT $0.640 (4.9%)

GRIN:CNX $0.095 (0%)

GRWG $4.390 (-2.23%)

GSTR:CNX $0.095 (-5%)

GTBIF $8.197 (-1.01%)

GTII:CNX $10.850 (-0.18%)

GWPH $106.620 (0.87%)

HEXO $2.240 (0.45%)

HHPHF $0.032 (0%)

HLSPY $0.640 (0%)

HMLSF $7.120 (0.34%)

HMPPF $0.498 (0%)

HRVOF $0.145 (14.36%)

HSTRF $0.244 (0%)

HUGE:CNX $5.800 (6.42%)

IAN:CNX $1.660 (-1.19%)

IGC $0.653 (-4.87%)

IGXT $0.540 (1.89%)

IIPR $74.010 (0.49%)

IMLFF $0.182 (0.78%)

INQD $0.002 (0%)

IONC:CNX $0.035 (40%)

IONKF $0.029 (43%)

ISOL:CNX $0.180 (2.86%)

ISOLF $0.138 (-0.14%)

ITHUF $1.260 (-0.79%)

IVITF $0.095 (-4.81%)

JWCAF $0.249 (24.5%)

KALTF $0.039 (-0.51%)

KBEV:CNX $0.150 (3.45%)

KBEVF $0.115 (9.52%)

KHRNF $0.695 (-3.2%)

KSHB $1.590 (-1.85%)

LHS:CNX $0.660 (1.54%)

LHSIF $0.500 (1.01%)

LOVE:CNX $0.130 (0%)

LXLLF $0.377 (0%)

LXRP $0.374 (-0.47%)

LXX:CNX $0.485 (1.04%)

MCIG $0.023 (-4.56%)

MDCL $2.830 (5.2%)

MEDIF $2.670 (-0.83%)

MGWFF $0.050 (42.86%)

MICWF $0.096 (0%)

MJ:CNX $0.145 (-3.33%)

MJNA $0.025 (-1.6%)

MNTR $0.080 (0%)

MRRCF $0.009 (29.96%)

MWM:CNX $0.120 (4.35%)

MYM:CNX $0.115 (0%)

MYMMF $0.090 (0.23%)

NCNNF $0.267 (-1.19%)

NDVAF $0.185 (8.82%)

NGW:CNX $0.110 (0%)

NRXCF $0.014 (0%)

NSPDF $0.050 (0%)

NTEC $0.507 (-0.65%)

NVTQF $0.123 (0%)

NWKRF $0.424 (0%)

NXGWF $0.085 (5.8%)

NXTTF $0.235 (2.17%)

OH:CNX $4.790 (10.88%)

ORHOF $3.600 (9.29%)

OWCP $0.007 (0.74%)

PHGI:CNX $0.295 (-1.67%)

PHGRF $0.219 (-4.94%)

PHVAF $0.080 (-13.66%)

PILL:CNX $0.435 (3.57%)

PKG:CNX $0.100 (-4.76%)

PLPRF $1.239 (1.29%)

PLUS:CNX $1.620 (2.53%)

PMCB $0.046 (-3.81%)

PNPL $0.160 (0%)

POTN $0.027 (1.11%)

PRCNF $0.070 (-3.18%)

PTNYF $0.076 (-1.64%)

QCA:CNX $0.110 (0%)

RDDTF $0.338 (9.03%)

RLLVF $0.023 (0%)

RMHB $0.021 (-6.61%)

RQB:CNX $0.120 (-4%)

RQHTF $0.390 (-0.03%)

RVVQF $0.091 (-9.2%)

SLNG:CNX $0.395 (1.28%)

SMG $101.650 (0.21%)

SNN:CNX $0.240 (-23.81%)

SNNVF $0.185 (-22.92%)

SOL:CNX $0.470 (6.82%)

SOLCF $0.360 (5.85%)

SPLIF $0.028 (-11.25%)

SPRWF $0.525 (5.62%)

SRNA $0.082 (-1.8%)

STEM:CNX $1.100 (0.92%)

STMH $0.840 (3.91%)

SUN:CNX $0.200 (5.26%)

TBPMF $0.390 (-1.79%)

TCAN:CNX $0.710 (10.94%)

TCNAF $0.495 (0%)

TER:CNX $2.450 (-6.13%)

TGEN $2.180 (-1.36%)

TGIF:CNX $0.205 (2.5%)

TGIFF $0.155 (0.65%)

THC:CNX $0.150 (0%)

THCBF $0.106 (-2.68%)

TLRY $18.600 (-1.74%)

TOKI:CNX $0.030 (-14.29%)

TRLFF $0.110 (-7.56%)

TRPX $1.319 (-0.8%)

TRSSF $1.848 (-3.91%)

TRTC $0.172 (-0.04%)

TURV $0.085 (3.03%)

VBIO $0.080 (33.33%)

VIDA:CNX $0.110 (-8.33%)

VIN:CNX $0.015 (0%)

VPRB $0.040 (24.61%)

VRNDF $0.378 (2.33%)

VRT:CNX $0.210 (0%)

VRTHF $0.080 (-42.86%)

VVCIF $0.153 (-2.68%)

WAYL:CNX $0.740 (0%)

WDDMF $0.677 (-3.02%)

WLDFF $0.154 (10.19%)

XXII $0.942 (5.21%)

ZDPY $0.248 (0%)

ZYNE $5.710 (-0.7%)

Technical420 Site Search

Returned 40 result(s).

Emerald Health Therapeutics Announces $25 Million Convertible Debenture Unit Financing

Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Investor has agreed, subject to certain customary conditions, to purchase 2,500 secured convertible debenture units (each, a “Convertible Debenture…

Emerald Health Therapeutics Appoints Chief Executive Officer

VICTORIA, British Columbia, July 30, 2019  -- Emerald Health Therapeutics, Inc. “Emerald” (TSXV: EMH; OTCQX: EMHTF) has appointed Riaz Bandali as Chief Executive Officer. Mr. Bandali has over 25 years of experience in life sciences, with expertise in global operations, strategy development, innovation cultivation, M&A, and investment management spanning contract…

Emerald Health Therapeutics Expands Distribution of its SYNC 25 CBD Oil to Two More Canadian Provinces

Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has shipped 9,960 40-ml units of its SYNC 25 CBD oil to Alberta and Saskatchewan. The Emerald-branded Indica-dominant CBD oil offers consumers a smoke-free product alternative. “CBD oil has become an increasingly popular product on the market today, and our cannabis-derived…

Emerald Health Therapeutics Joint Venture Launches Cannabis-Free Endocannabinoid-Supporting Health Supplement in Canada

Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), through its joint venture Emerald Health Naturals (“EHN”), has introduced a cannabis-free herbal and botanical endocannabinoid-supporting health supplement product line in Canada. EHN’s Endo products, which do not contain cannabis or its derivatives, aim to support the endocannabinoid system to help…

Emerald Health Therapeutics Announces Pure Sunfarms’ Receipt of Standard Processing License for Delta 3 Greenhouse Facility

Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received a Standard Processing License (the “Processing License”) from Health Canada for its 1.1 million square foot Delta 3 greenhouse facility. The Processing License permits Pure…

Emerald Health Therapeutics Reports Fourth Quarter and Fiscal 2018 Financial Results; Highlights Sales Growth in Q1 2019

Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the fourth quarter and year ended December 31, 2018. Highlights Emerald’s Q4 sales of $1.1 million was more than triple the prior quarter and year-over year; Q1 2019 sales were $2.6 million. Quebec-based Verdélite subsidiary expected to…

Emerald Health Therapeutics Secures Proprietary Extraction Technology and Extraction Capabilities in Agreement with Indena

Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) has entered into a license with Indena S.p.A. of Milan, Italy, bearing certain exclusivity rights in Canada to use Indena’s cannabidiol extraction technology, and contract manufacturing services for CBD extraction. In addition, Emerald has obtained exclusive use of Indena’s proprietary Phytosome® technology for the…

Whole Foods Market Enters the Endocannabinoid Category with Emerald Health Bioceuticals

Emerald Health Bioceuticals (EHB), a leading provider of nutritional supplements formulated to support the human endocannabinoid system, today announced that its award-winning Endo product line is now available nationwide in Whole Foods Market. Cannabis-based products, including CBD, are not legally allowed to be sold in traditional health, food, drug and…

Emerald Health sees Expansion of Pure Sunfarms’ Cannabis Cultivation License to 825,000 Square Feet

Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) announced that its 50%-owned joint venture focused on large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada its sixth amendment to its cultivation license for its 1.1 million square foot greenhouse in Delta, BC. The additional approximately 138,000 square feet brings Pure…

Emerald Health Therapeutics Announces Secondary Offering

Emerald Health Therapeutics, Inc. (TSXV:EMH) today announced that Emerald Health Sciences Inc. has entered into a share purchase agreement with a single Canadian institutional accredited investor in connection with a secondary offering of common shares of the Company. Pursuant to the Share Purchase Agreement, the Investor will purchase 2,800,000 common shares of the Company from…

Older Posts »

Search Again